Intraethnic variation in steroid-5-alpha-reductase polymorphismsin prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment

J Genet. 2015 Jun;94(2):335-41. doi: 10.1007/s12041-015-0511-3.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase / genetics*
  • 5-alpha Reductase Inhibitors / therapeutic use*
  • Ethnicity / genetics*
  • Gene Frequency / genetics
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Polymorphism, Single Nucleotide / genetics*
  • Principal Component Analysis
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / enzymology
  • Prostatic Neoplasms / genetics*

Substances

  • 5-alpha Reductase Inhibitors
  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase